Fingerprint
Dive into the research topics of 'Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically